Comment
doi: 10.1001/jamaophthalmol.2019.3964.
Antimetabolite Therapy for Uveitis: Methotrexate or Mycophenolate?
Affiliations
- PMID: 31503274
- DOI: 10.1001/jamaophthalmol.2019.3964
Item in Clipboard
Comment
Antimetabolite Therapy for Uveitis: Methotrexate or Mycophenolate?
JAMA Ophthalmol.
.
No abstract available
Comment in
-
Stratification Clarification for Methods for Randomized Clinical Trials.JAMA Ophthalmol. 2020 Jul 1;138(7):800-801. doi: 10.1001/jamaophthalmol.2020.1551. JAMA Ophthalmol. 2020. PMID: 32437493 No abstract available.
-
Stratification Clarification for Methods for Randomized Clinical Trials-Reply.JAMA Ophthalmol. 2020 Jul 1;138(7):801. doi: 10.1001/jamaophthalmol.2020.1864. JAMA Ophthalmol. 2020. PMID: 32437500 Free PMC article. No abstract available.
Comment on
-
Effect of Corticosteroid-Sparing Treatment With Mycophenolate Mofetil vs Methotrexate on Inflammation in Patients With Uveitis: A Randomized Clinical Trial.JAMA. 2019 Sep 10;322(10):936-945. doi: 10.1001/jama.2019.12618. JAMA. 2019. PMID: 31503307 Free PMC article. Clinical Trial.
Similar articles
-
A Bayesian Analysis of a Randomized Clinical Trial Comparing Antimetabolite Therapies for Non-Infectious Uveitis.Ophthalmic Epidemiol. 2017 Feb;24(1):63-70. doi: 10.1080/09286586.2016.1255764. Epub 2016 Dec 16. Ophthalmic Epidemiol. 2017. PMID: 27982726 Free PMC article. Clinical Trial.
-
Comparison of antimetabolite drugs as corticosteroid-sparing therapy for noninfectious ocular inflammation.Ophthalmology. 2008 Oct;115(10):1826-32. doi: 10.1016/j.ophtha.2008.04.026. Epub 2008 Jun 25. Ophthalmology. 2008. PMID: 18579209
-
Effect of Corticosteroid-Sparing Treatment With Mycophenolate Mofetil vs Methotrexate on Inflammation in Patients With Uveitis: A Randomized Clinical Trial.JAMA. 2019 Sep 10;322(10):936-945. doi: 10.1001/jama.2019.12618. JAMA. 2019. PMID: 31503307 Free PMC article. Clinical Trial.
-
Treatment of chronic non-infectious uveitis and scleritis.Swiss Med Wkly. 2019 Mar 10;149:w20025. doi: 10.4414/smw.2019.20025. eCollection 2019 Feb 25. Swiss Med Wkly. 2019. PMID: 30852832
-
[Treatment of uveitis with immunosuppressives: antimetabolites and alkylating agents].Bull Soc Belge Ophtalmol. 2001;(279):49-59. Bull Soc Belge Ophtalmol. 2001. PMID: 11344715 Review. French.
Cited by
-
Next-generation nanomaterials: advancing ocular anti-inflammatory drug therapy.J Nanobiotechnology. 2023 Aug 19;21(1):282. doi: 10.1186/s12951-023-01974-4. J Nanobiotechnology. 2023. PMID: 37598148 Free PMC article. Review.
-
Non-biologic, steroid-sparing therapies for non-infectious intermediate, posterior, and panuveitis in adults.Cochrane Database Syst Rev. 2022 Oct 31;10(10):CD014831. doi: 10.1002/14651858.CD014831.pub2. Cochrane Database Syst Rev. 2022. PMID: 36315029 Free PMC article.
-
The Conundrum of Clinical Trials for the Uveitides: Appropriate Outcome Measures for One Treatment Used in Several Diseases.Epidemiol Rev. 2022 Dec 21;44(1):2-16. doi: 10.1093/epirev/mxac001. Epidemiol Rev. 2022. PMID: 35442407 Free PMC article.
-
Stratification Clarification for Methods for Randomized Clinical Trials-Reply.JAMA Ophthalmol. 2020 Jul 1;138(7):801. doi: 10.1001/jamaophthalmol.2020.1864. JAMA Ophthalmol. 2020. PMID: 32437500 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
